Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 15;7(10):e019301.
doi: 10.1136/bmjopen-2017-019301.

Probiotics administered intravaginally as a complementary therapy combined with antibiotics for the treatment of bacterial vaginosis: a systematic review protocol

Affiliations

Probiotics administered intravaginally as a complementary therapy combined with antibiotics for the treatment of bacterial vaginosis: a systematic review protocol

Liyan Ma et al. BMJ Open. .

Abstract

Introduction: Bacterial vaginosis (BV) is a highly prevalent vaginal polymicrobial disorder commonly encountered in women of childbearing age. Therapy with only recommended antibiotics results in low cure rates and unacceptably high recurrence rates. The use of probiotics as a complementary approach for use with antibiotics for the treatment of BV remains unclear. This review aims to assess the efficacy of lactobacilli administered intravaginally in conjunction with antibiotics for the treatment of BV.

Methods and analysis: The Cochrane Central Register of Controlled Trials in The Cochrane Library, Cochrane Library of Systematic Reviews, Medline/PubMed and Embase will be used to search for articles from database inception to November 2016. Randomised controlled clinical trials using lactobacilli administered intravaginally in conjunction with antibiotics to treat BV will be included. Primary outcome will be the BV cure rate. The recurrence rate will be examined as secondary outcome. Two reviewers will independently select trials and extract data from the original publications. The risk of bias will be assessed according to the Cochrane Risk of Bias tool. We will perform data synthesis using the Review Manager (RevMan) software V.5.2.3. To assess heterogeneity, we will compute the I2 statistic.

Ethics and dissemination: This study will be a review of published data and it is not necessary to obtain ethical approval. Findings of this systematic review will be published in a peer-reviewed journal.

Trial registration number: International Prospective Register of Systematic Reviews 2014: CRD42014015079.

Keywords: bacteriology; genitourinary medicine; microbiology; urogynaecology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flow diagram of the search for eligible studies on the probiotics administered intravaginally as a complementary therapy in combination with antibiotics for the treatment of bacterial vaginosis. CENTRAL, Cochrane Central Register of Controlled Trials; STI, sexually transmitted infection.

Similar articles

Cited by

References

    1. Walker J, Hocking JS, Fairley CK, et al. The prevalence and incidence of bacterial vaginosis in a cohort of young Australian women In:Conference proceedings of the International Society for Sexually Transmitted Diseases Research Quebec, Canada, 2011. - PubMed
    1. Kenyon C, Colebunders R, Crucitti T. The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol 2013;209:505–23. 10.1016/j.ajog.2013.05.006 - DOI - PubMed
    1. Dingens AS, Fairfortune TS, Reed S, et al. Bacterial vaginosis and adverse outcomes among full-term infants: a cohort study. BMC Pregnancy Childbirth 2016;16:278–86. 10.1186/s12884-016-1073-y - DOI - PMC - PubMed
    1. Leitich H, Kiss H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2007;21:375–90. 10.1016/j.bpobgyn.2006.12.005 - DOI - PubMed
    1. Cohen CR, Lingappa JR, Baeten JM, et al. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med 2012;9:e1001251 10.1371/journal.pmed.1001251 - DOI - PMC - PubMed

Substances